Myocardial infarction and remodeling in mice: Effect of reperfusion

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 2 46-2, 1999, Pages

  Michael, Lloyd H ^a   Ballantyne, Christie M ^a   Zachariah, Justin P ^a   Gould, Kenneth E ^b   Pocius, Jennifer S ^a   Taffet, George E ^a   Hartley, Craig J ^a   Pham, Thuy T ^a   Daniel, Sherita L ^a   Funk, Etai ^a   Entman, Mark L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Coronary artery occlusion; Ejection fraction; Hypertrophy; Nuclear imaging; Systolic and diastolic function

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIASTOLE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HEART VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HISTOLOGY; HYPERTROPHY; IMAGING; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTOLE;

EID: 0032878744     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.2.h660     Document Type: Article

References (46)

1. Birdsall, H. H., D. M. Green, J. Trial, K. A. Youker, A. R. Burns, C. R. Mackay, G. J. LaRosa, H. K. Hawkins, C. W. Smith, L. H. Michael, M. L. Entman, and R. D. Rossen. Complement C5a TGF-β1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion. Circulation 95: 684-692, 1997.
2. Bonaduce, D., M. Petretta, B. Villari, R. Breglio, G. Conforti, M. V. Montemurro, T. Lanzillo, and G. Morgano. Effects of late administration of tissue-type plasminogen activator on left ventricular remodeling and function after myocardial infarction. J. Am. Coll. Cardiol. 16: 1561-1568, 1990.
3. Boyle, M. P., and H. F. Weisman. Limitation of infarct expansion and ventricular remodeling by late reperfusion. Circulation 88: 2872-2883, 1993.
4. Dalen, J. E., J. M. Gore, E. Braunwald, J. Borer, R. J. Goldberg, E. R. Passamani, S. Forman, and G. Knatterud. Six-and twelve-month follow-up of the phase I thrombolysis in myocardial infarction (TIMI) trial. Am. J. Cardiol. 62: 179-185, 1988.
5. Entman, M. L., and C. W. Smith. Post-reperfusion inflammation: a model of reaction to injury in cardiovascular disease. Cardiovasc. Res. 28: 1301-1311, 1994.
6. Entman, M. L., K. A. Youker, T. Shoji, G. L. Kukielka, S. B. Shappell, A. A. Taylor, and C. W. Smith. Neutrophil induced oxidative injury of cardiac myocytes: A compartmented system requiring CD11b/CD18-ICAM-1 adherence. J. Clin. Invest. 90: 1335-1345, 1992.
7. Franciosa, J. A., M. Park, and T. B. Levine. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am. J. Cardiol. 47: 33-39, 1981.
8. Frangogiannis, N. G., M. L. Lindsey, L. H. Michael, K. A. Youker, R. B. Bressler, L. H. Mendoza, R. N. Spengler, C. W. Smith, and M. L. Entman. Resident cardiac mast cells degranulate and release preformed TNF-α initiating the cytokine cascade in myocardial ischemia/reperfusion. Circulation 98: 699-710, 1998.
9. Gruber, B. L., M. J. Marchese, and R. Kew. Angiogenic factors stimulate mast-cell migration. Blood 86: 2498-2493, 1995.
10. Hartley, C. J., J. L. Lacy, D. Dai, N. Nayak, G. E. Taffet, M. L. Entman, and L. H. Michael. Functional cardiac imaging in mice using Ta-178. Nat. Med. 5: 237-239, 1999.
11. Hartley, C. J., J. L. Lacy, J. Pocius, S. Daniel, E. Funk, G. E. Taffet, N. Nayak, M. L. Entman, and L. H. Michael. Characterization of a murine model of heart failure by nuclear angiography (Abstract). FASEB J. 12: A407, 1998.
12. Hartley, C. J., L. A. Latson, L. H. Michael, C. L. Seidel, R. M. Lewis, and M. L. Entman. Doppler measurement of myocardial thickening with a single epicardial transducer. Am. J. Physiol. 245 (Heart Circ. Physiol. 14): H1066-H1072, 1983.
13. Hartley, C. J., L. H. Michael, and M. L. Entman. Noninvasive measurement of ascending aortic blood velocity in mice. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H499-H505, 1995.
14. Heaney, L. G., L. J. Cross, C. F. Stanford, and M. Ennis. Substance P induces histamine release from human pulmonary mast cells. Clin. Exp. Allergy 25: 179-186, 1995.
15. Hirayama, A., T. Adachi, S. Asada, M. Mishima, S. Nanto, H. Kusuoka, K. Yamamoto, Y. Matsumura, M. Hori, M. Inoue, and K. Kodama. Late reperfusion for acute myocardial infarction limits the dilatation of left ventricle without the reduction of infarct size. Circulation 88: 2565-2574, 1993.
16. Isaaz, K., G. Ethevenot, P. Admant, B. Brembilla, and C. Pernot. A new Doppler method of assessing left ventricular ejection force in chronic congestive heart failure. Am. J. Cardiol. 64: 81-87, 1989.
17. Isaaz, K., G. Ethevenot, P. Admant, B. Brembilla, and C. Pernot. A simplified normalized ejection phase index measured by Doppler echocardiography for the assessment of left ventricular performance. Am. J. Cardiol. 65: 1246-1251, 1990.
18. ISIS (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2: 349-360, 1989.
19. Kennedy, J. W., J. L. Ritchie, K. B. Davis, M. L. Stadius, C. Maynard, and J. K. Fritz. The Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction: a 12-month follow-up report. N. Engl. J. Med. 312: 1073-1078, 1985.
20. Kubota, T., C. F. McTiernan, C. S. Frye, S. E. Slawson, A. P. Koretsky, A. J. Demetris, and A. M. Feldman. Dilated cardiomyopathy in transgenic mice with cardiac specific overexpression of tumor necrosis factor-α. Circ. Res. 81: 627-635, 1998.
21. Kumar, A. G., C. M. Ballantyne, L. H. Michael, G. L. Kukielka, K. A. Youker, M. L. Lindsey, H. K. Hawkins, H. H. Birdsall, C. R. Mackay, G. J. LaRosa, R. D. Rossen, C. W. Smith, and M. L. Entman. Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation 95: 693-700, 1997.
22. Labovitz, A. J., A. C. Pearson, and B. R. Chaitman. Doppler and two-dimensional echocardiographic assessment of left ventricular function before and after intravenous dipyridamole stress testing for detection of coronary artery disease. Am. J. Cardiol. 62: 1180-1185, 1988.
23. Li, B., Q. Li, X. Wang, K. P. Jana, G. Redaelli, J. Kajstura, and P. Anversa. Coronary constriction impairs cardiac function and induces myocardial damage and ventricular remodeling in mice. Am. J. Physiol. 273 (Heart Circ. Physiol. 42): H2508-H2519, 1997.
24. Lu, H., C. W. Smith, J. Perrard, D. Bullard, L. Tang, S. B. Shappell, M. L. Entman, A. L. Beaudet, and C. M. Ballantyne. LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice. J. Clin. Invest. 99: 1340-1350, 1997.
25. Marino, P., L. Zanolla, and R. Zardini. Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI trial. J. Am. Coll. Cardiol. 14: 149-158, 1989.
26. Mehdirad, A. A., G. A. Williams, A. J. Labovitz, R. J. Bryg, and B. R. Chaitman. Evaluation of left ventricular function during upright exercise: correlation of exercise Doppler with postexercise two-dimensional echocardiographic results. Circulation 75: 413-419, 1987.
27. Michael, L. H., M. L. Entman, C. J. Hartley, K. A. Youker, J. Zhu, S. R. Hall, H. K. Hawkins, K. Berens, and C. M. Ballantyne. Myocardial ischemia and reperfusion: a murine model. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H2147-H2154, 1995.
28. Morita, M., S. Kawashima, M. Ueno, A. Kubota, and T. Iwasaki. Effects of late reperfusion on infarct expansion and infarct healing in conscious rats. Am. J. Pathol. 143: 419-430, 1993.
29. Nidorf, S. M., S. C. Siu, G. Galambos, A. E. Weyman, and M. H. Picard. Benefit of late coronary reperfusion on ventricular morphology and function after myocardial infarction. J. Am. Coll. Cardiol. 21: 683-691, 1993.
30. Patten, R. D., M. J. Aronovitz, L. Deras-Mejia, N. G. Pandian, G. G. Hanak, J. J. Smith, M. E. Mendelsohn, and M. A. Konstam. Ventricular remodeling in a mouse model of myocardial infarction. Am. J. Physiol. 274 (Heart Circ. Physiol. 43): H1812-H1820, 1998.
31. Pennington, D. W., A. R. Lopez, P. S. Thomas, C. Peck, and W. M. Gold. Dog mastocytoma cells produce transforming growth factor beta 1. J. Clin. Invest. 90: 35-41, 1992.
32. Pfeffer, M. A., and E. Braunwald. Ventricular remodeling after myocardial infarction. Circulation 81: 1161-1172, 1990.
33. Pfeffer, M. A., J. M. Pfeffer, C. Steinberg, and P. Finn. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 72: 406-412, 1985.
34. Pierce, G. F., T. A. Mustoe, J. Lingelbach, V. R. Masakowski, G. L. Griffin, R. M. Senior, and T. F. Deuel. Platelet-derived growth factor and transforming growth factor-β enhance tissue repair activities by unique mechanisms. J. Cell Biol. 109: 429-440, 1989.
35. Richard, V., C. E. Murry, and K. A. Reimer. Healing of myocardial infarcts in dogs: effects of late reperfusion. Circulation 92: 1891-1901, 1995.
36. Rizzo, V., and D. O. Defoux. Mast cell activation accelerates the normal rate of angiogenesis in the chick chorioallantoic membrane. Microvasc. Res. 52: 245-257, 1996.
37. Ruoss, S. J., T. Hartmann, and G. H. Caughey. Mast cell tryptase is a mitogen for cultured fibroblasts. J. Clin. Invest. 88: 493-499, 1991.
38. Sabbah, H. N., J. Przybylski, D. E. Albert, and P. D. Stein. Peak aortic blood acceleration reflects the extent of left ventricular ischemic mass at risk. Am. Heart J. 113: 885-890, 1987.
39. Schieffer, B., A. Wirger, M. Meybrunn, S. Seitz, J. Holtz, U. N. Riede, and H. Drexler. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockage on cardiac remodeling after myocardial infarction in the rat. Circulation 89: 2273-2282, 1994.
40. Sligh, J. E., Jr., C. M. Ballantyne, S. S. Rich, H. K. Hawkins, C. W. Smith, A. Bradley, and A. L. Beaudet. Inflammatory and immune responses are impaired in ICAM-1 deficient mice. Proc. Natl. Acad. Sci. USA 90: 8529-8533, 1993.
41. Taffet, G. E., C. J. Hartley, X. Wen, T. Pham, L. H. Michael, and M. L. Entman. Noninvasive indexes of cardiac systolic and diastolic function in hyperthyroid and senescent mouse. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H2204-H2209, 1996.
42. Topol, E. J., R. M. Califf, C. L. Grines, B. S. George, M. L. Sanz, T. Wall, M. O'Brien, M. Schwaiger, F. V. Aguirre, S. Young, J. J. Pompa, K. N. Sigmon, K. L. Lee, S. Ellis, and Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group. A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and angioplasty in myocardial infarction-6 study group. Circulation 85: 2090-2099, 1992.
43. Uusimaa, P., J. Risteli, M. Niemela, J. Lumme, M. Ikaheimo, A. Jounela, and K. Peuhkurinen. Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency. Circulation 96: 2565-2572, 1997.
44. Verani, M. S., J. L. Lacy, G. W. Guidry, S. Nishimura, J. J. Mahmarian, T. Athanasoulis, and R. Roberts. Quantification of left ventricular performance during transient coronary occlusion at various anatomic sites in humans: a study using tantalum-178 and a multiwire gamma camera. J. Am. Coll. Cardiol. 19: 297-306, 1992.
45. Villari, B., F. Piscione, D. Bonaduce, P. Golino, T. Lanzillo, M. Condorelli, and M. Chiariello. Usefulness of late coronary thrombolysis (recombinant tissue-type plasminogen activator) in preserving left ventricular function in acute myocardial infarction. Am. J. Cardiol. 66: 1281-1286, 1990.
46. Wershil, B. K., and S. J. Galli. The analysis of mast cell function in vivo using mast cell-deficient mice. Adv. Exp. Med. Biol. 347: 39-54, 1994.